NO853100L - Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-pyridiner. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-pyridiner.

Info

Publication number
NO853100L
NO853100L NO853100A NO853100A NO853100L NO 853100 L NO853100 L NO 853100L NO 853100 A NO853100 A NO 853100A NO 853100 A NO853100 A NO 853100A NO 853100 L NO853100 L NO 853100L
Authority
NO
Norway
Prior art keywords
procedure
preparation
therapeutic active
active imidazo
imidazo pyridines
Prior art date
Application number
NO853100A
Other languages
English (en)
Other versions
NO162189B (no
NO162189C (no
Inventor
Pascal George
Claudie Giron
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO853100L publication Critical patent/NO853100L/no
Publication of NO162189B publication Critical patent/NO162189B/no
Publication of NO162189C publication Critical patent/NO162189C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO853100A 1984-08-07 1985-08-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner. NO162189C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8412447A FR2568880B1 (fr) 1984-08-07 1984-08-07 Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO853100L true NO853100L (no) 1986-02-10
NO162189B NO162189B (no) 1989-08-14
NO162189C NO162189C (no) 1989-11-29

Family

ID=9306856

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853100A NO162189C (no) 1984-08-07 1985-08-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.

Country Status (23)

Country Link
US (1) US4650796A (no)
EP (1) EP0172096B1 (no)
JP (1) JPS6147485A (no)
KR (1) KR910004450B1 (no)
AR (1) AR241185A1 (no)
AT (1) ATE40365T1 (no)
AU (1) AU575190B2 (no)
CA (1) CA1261830A (no)
CZ (1) CZ357691A3 (no)
DE (1) DE3567867D1 (no)
DK (1) DK163923C (no)
ES (1) ES8604592A1 (no)
FI (1) FI80696C (no)
FR (1) FR2568880B1 (no)
GR (1) GR851928B (no)
HU (1) HU193799B (no)
IE (1) IE58347B1 (no)
IL (1) IL76020A (no)
MX (1) MX160845A (no)
NO (1) NO162189C (no)
NZ (1) NZ213013A (no)
PT (1) PT80921B (no)
ZA (1) ZA855939B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593180B1 (fr) * 1986-01-22 1990-10-26 Synthelabo Derives d'acylaminomethyl-1 imidazo (1,2-a)quinoleines, leur preparation et leur application en therapeutique
ES2032455T3 (es) * 1986-01-22 1993-02-16 Synthelabo Procedimiento para preparar derivados de 3-acilaminometil-imidazo (-1,2-a)piridinas.
FR2593818B1 (fr) * 1986-02-05 1988-04-29 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique
US4990506A (en) * 1986-02-05 1991-02-05 Synthelabo 3-(acylaminomethyl)imidazo[1,2-a]pyridine derivatives and their application in therapy
FR2606409B1 (fr) * 1986-11-07 1989-05-05 Synthelabo Derives d'imidazopyridine, leur preparation et leur application en therapeutique
ES2026666T3 (es) * 1987-03-27 1992-05-01 Synthelabo Procedimiento para preparar derivados de imidazopiridinas.
FR2615513B1 (fr) * 1987-05-21 1989-07-13 Synthelabo Derives d'acylaminomethyl-3 tetrahydro-5,6,7,8 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2654933B1 (fr) * 1989-11-30 1994-06-10 Synthelabo Utilisation d'une imidazopyridine pour la fabrication de medicaments anesthesiques.
KR910011852A (ko) * 1989-12-04 1991-08-07 폴 디. 매튜카이티스 신경독 장해 치료용 이미다조[1,2-a]피리디닐알킬 화합물
IE904346A1 (en) * 1989-12-04 1991-06-05 Searle & Co IMIDAZO[1,2-a]PYRIDINYLALKYL COMPOUNDS FOR TREATMENT OF¹NEUROTOXIC INJURY
US5716964A (en) * 1989-12-04 1998-02-10 G.D. Searle & Co. Tetrazolyl substituted imidazo 1,2-a!pyridinylalkyl compounds for treatment of neurotoxic injury
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
AUPP278498A0 (en) 1998-04-03 1998-04-30 Australian Nuclear Science & Technology Organisation Peripheral benzodiazepine receptor binding agents
DE10019714A1 (de) * 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
WO2002002557A2 (en) * 2000-06-30 2002-01-10 Neurogen Corporation 2-phenylimidazo[1,2-a]pyridine derivatives: a new class of gaba brain receptor ligands
US6596731B2 (en) 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
DE10247269A1 (de) 2002-10-10 2004-04-22 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yl-methylamine
US7723324B2 (en) * 2003-10-28 2010-05-25 Sepracor, Inc. Imidazo[1,2-A]pyridine anxiolytics
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
FR2874611B1 (fr) * 2004-08-31 2006-11-17 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2007121864A (ru) * 2004-11-11 2008-12-20 Феррер Интернасионал ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ), КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ РЕЦЕПТОРОВ GABAA, ИЛИ α1-GABAA, ИЛИ α2-GABAA (ВАРИАНТЫ)
US8178533B2 (en) 2005-06-01 2012-05-15 Ucb Pharma, S.A. 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
US20100222326A1 (en) * 2007-04-27 2010-09-02 Ucb Pharma, S.A. New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
CA2724842A1 (en) * 2008-05-19 2009-11-26 Sunovion Pharmaceuticals Inc. Imidazo[1,2-a]pyridine compounds
EP2376490B1 (en) * 2008-12-04 2013-01-23 Proximagen Limited Imidazopyridine compounds
SG11201509650YA (en) 2013-05-24 2015-12-30 Iomet Pharma Ltd Slc2a transporter inhibitors
WO2017087885A1 (en) 2015-11-19 2017-05-26 Dana-Farber Cancer Institute, Inc. Methods of identifying compounds that interfere with erg-driven misguidance of baf complexes in tmprss2-erg driven prostate cancers
US11497752B2 (en) 2018-01-30 2022-11-15 Foghorn Therapeutics Inc. Compounds and uses thereof
WO2020081588A1 (en) 2018-10-17 2020-04-23 Dana-Farber Cancer Institute, Inc. Swi/snf family chromatin remodeling complexes and uses thereof
KR102797127B1 (ko) * 2018-12-29 2025-04-21 우한 크리에이터나 사이언스 앤드 테크놀로지 컴퍼니, 리미티드 헤테로고리계 화합물, 중간체, 이의 제조 방법 및 용도
US12509453B2 (en) 2019-01-29 2025-12-30 Foghorn Therapeutics Inc. BRM/BRG1 inhibitors and uses thereof
US12384776B2 (en) 2019-01-29 2025-08-12 Foghorn Therapeutics Inc. Compounds and uses thereof
AU2021213811A1 (en) 2020-01-29 2022-07-28 Foghorn Therapeutics Inc. Compounds and uses thereof
WO2021155264A1 (en) * 2020-01-29 2021-08-05 Foghorn Therapeutics Inc. Compounds and uses thereof
US12383555B2 (en) 2020-05-20 2025-08-12 Foghorn Therapeutics Inc. Methods of treating cancers
US12606553B2 (en) 2021-03-09 2026-04-21 Foghorn Therapeutics Inc. Crystalline forms, compositions containing same, and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB991589A (en) * 1963-04-30 1965-05-12 Selvi & C Lab Bioterapico Novel [1,2-ª‡]imidazopyridines and a process for the manufacture thereof
GB1076089A (en) * 1965-11-09 1967-07-19 Selvi & C Lab Bioterapico New derivatives of imidazo [1,2-a]-pyridine and a process for the manufacture thereof

Also Published As

Publication number Publication date
FR2568880A1 (fr) 1986-02-14
PT80921B (pt) 1987-12-30
DE3567867D1 (en) 1989-03-02
PT80921A (fr) 1985-09-01
FI80696B (fi) 1990-03-30
AU4580985A (en) 1986-02-13
NZ213013A (en) 1988-05-30
CA1261830A (en) 1989-09-26
ZA855939B (en) 1986-03-26
KR910004450B1 (ko) 1991-06-29
DK163923B (da) 1992-04-21
HU193799B (en) 1987-11-30
NO162189B (no) 1989-08-14
FR2568880B1 (fr) 1986-12-12
EP0172096A1 (fr) 1986-02-19
IL76020A0 (en) 1985-12-31
AU575190B2 (en) 1988-07-21
EP0172096B1 (fr) 1989-01-25
FI80696C (fi) 1990-07-10
GR851928B (no) 1985-12-09
FI853026L (fi) 1986-02-08
IE851937L (en) 1986-02-07
FI853026A0 (fi) 1985-08-06
ES8604592A1 (es) 1986-02-01
IL76020A (en) 1989-01-31
JPS6147485A (ja) 1986-03-07
ES545928A0 (es) 1986-02-01
NO162189C (no) 1989-11-29
ATE40365T1 (de) 1989-02-15
DK163923C (da) 1992-09-14
US4650796A (en) 1987-03-17
DK356885A (da) 1986-02-08
IE58347B1 (en) 1993-09-08
KR860001809A (ko) 1986-03-22
DK356885D0 (da) 1985-08-06
HUT38637A (en) 1986-06-30
JPH0523267B2 (no) 1993-04-02
CZ357691A3 (en) 1993-06-16
AR241185A1 (es) 1992-01-31
MX160845A (es) 1990-05-31

Similar Documents

Publication Publication Date Title
NO853100L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-pyridiner.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO853293L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO870526D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO884231D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazopyridin-derivater.
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO853099L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-kinoliner.
NO865012L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater.
NO873835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
NO162617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO854277L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater.